You are here

oncology

Novartis Out To Prove Its Oncology Doubters Wrong

Seeking Alpha

Sat, 01/28/17 - 02:22 pm

Biogen spinoff begins trading today; New oncology chief at AstraZeneca

Endpoints

Fri, 01/13/17 - 11:18 am

Novartis, Sun Pharma enter deal for oncology drug Odomzo

BioPharma Dive

Sat, 12/24/16 - 12:23 pm

Study: IBM Watson agrees with cancer docs on treatment options 90% of the time

Fierce Biotech

Fri, 12/9/16 - 09:43 am

artificial intelligence

Merck Laughs Its Way To The Bank With Breakthrough Cancer Drug Keytruda

Seeking Alpha

Thu, 12/8/16 - 10:02 am

AbbVie’s Imbruvica Expected to Become a Leading Oncology Drug

Market Realist

Tue, 11/29/16 - 09:46 am

Novartis’ recently departed oncology R&D chief is headed back to Dana-Farber and a new job in cancer research

Endpoints

Wed, 11/23/16 - 10:18 am

Astellas furthers oncology focus with Ganymed buy

BioPharma Dive

Fri, 10/28/16 - 05:48 pm

gastroesophageal cancer

AstraZeneca backs ADC in $105M to support 6 clinical oncology candidates

Fierce Biotech

Tue, 10/18/16 - 11:22 am

ADC Therapeutics

Clinical trial roundup 2015 (infographic)

CP Wire

Tue, 10/18/16 - 10:21 am

clinical trials

Amgen inks latest high price-tag research collaboration

BioPharma Dive

Tue, 10/4/16 - 10:14 pm

The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing

Cafepharma/Globe Newswire

Tue, 10/4/16 - 09:42 am

Myriad Genetics

UroToday.com, Leading Urology Reference Site, Launches New Publication: Everyday Urology-Oncology Insights

CP Wire

Wed, 09/14/16 - 03:51 pm

The secretive system for vetting cancer drug use needs an urgent overhaul

Stat/Pharmalot

Tue, 09/6/16 - 09:50 am

Ibrance and Xtandi Could Be in the Top 10 Oncology Drugs by 2021

Market Realist

Mon, 08/29/16 - 04:16 pm

prostate cancer

Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Medivation Could Be a Smart Move)

Motley Fool

Fri, 08/26/16 - 10:00 am

What’s the hottest biotech R&D field in venture investing?

Endpoints

Fri, 07/22/16 - 11:27 am

venture capital

Where Are the Opportunities for Varian’s Oncology Business?

Market Realist

Mon, 07/11/16 - 09:14 am

Top Officials Aim To Reshape The FDA To Prepare For 'Avalanche' Of Cancer Products

Forbes

Thu, 06/30/16 - 09:44 am

Payer interest grows in outcomes-based drug deals: report

BioPharma Dive

Fri, 06/17/16 - 09:33 pm

pay-for-performance

Pages